Regression modeling of competing risk using R: an in depth guide for clinicians

R语言竞争风险回归建模：临床医生的深度指南

2010-1-11

A novel mouse model of acute graft-versus-host disease based on chemotherapy conditioning and G-CSF mobilized graft

基于化疗预处理和G-CSF动员移植的新型急性移植物抗宿主病小鼠模型

2019-9-26

Post-transplantation cyclophosphamide for chimerism-based tolerance.

基于嵌合体耐受的移植后环磷酰胺治疗。

2019-8-1

A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

一种治疗重度获得性再生障碍性贫血的新型半相同造血干细胞移植协议，无需体外T细胞去除

2012-5-28

Gender equality in wine and medicine

葡萄酒与医学中的性别平等

2024-11-11

Successful allogeneic CD34+ hematopoietic stem cell boost for prolonged cytopenias following CAR T-cell therapy in B-cell acute lymphoblastic leukemia. On behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)

B细胞急性淋巴细胞白血病中CAR T细胞治疗后持续性细胞减少症成功接受同种异体CD34+造血干细胞增强治疗。代表西班牙造血移植与细胞治疗小组（GETH-TC）

2024-11-17

Pretransplantation risk factors for positive MRD after allogeneic stem cell transplantation in AML patients: a prospective study

异基因造血干细胞移植前风险因素对AML患者移植后微小残留病阳性的影响：一项前瞻性研究

2024-11-16

Comparing stem cell mobilization with chemotherapy and cytokine (G-CSF) versus cytokine alone in myeloma patients (MOCCCA): a randomized phase II, open-label, non-inferiority trial

比较干细胞动员与化疗及细胞因子（G-CSF）联合治疗与单独使用细胞因子治疗多发性骨髓瘤患者的疗效（MOCCCA）：一项随机、开放标签、非劣效性II期试验

2024-11-15

Post-transplant-cyclophosphamide plus everolimus as GvHD prophylaxis in refractory T- and B-cell lymphoma

难治性T和B细胞淋巴瘤中移植后环磷酰胺联合依维莫司作为移植物抗宿主病预防

2024-11-15

Correction: Hematopoietic stem cell transplantation activity in China 2022–2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese Blood and Marrow Transplantation Registry Group

更正：2022-2023年中国造血干细胞移植活动。干细胞来源中外周血的比例持续增长：来自中国血液和骨髓移植登记组的报告

2024-11-15